Today news
About the same in other media
Cathie Wood says her firm is testing a more aggressive strategy that would be 'ARK on steroids'
Reading now: 817
cnbc.comCathie Wood — known for her innovation ETFs that garnered billions in inflows during the pandemic — said Ark Invest is internally testing a fund that takes the strategy a step further by simultaneously betting against major stocks in the benchmarks that are being disrupted.
«We're testing out a portfolio but it's really Ark on steroids,» Wood told CNBC's «Squawk Box» on Wednesday. Wood said she wants to test the strategy on Ark's employees and did not say when the fund would be made available to retail investors.
«We think the benchmarks are where the big risks are long-term because they are filling up with value-traps, those companies that have done very well historically but are going to be disintermediated and disrupted by the massive
Read more on cnbc.comAbout this in other media
Ark Invest’s Cathie Wood calls metaverse a ‘big idea that will infiltrate every sector’ ambcrypto.com /2 years ago
All of the stocks in Cathie Wood's Ark Innovation fund are in a bear market except 2 cnbc.com /2 years ago
Shell to go ahead with seismic tests in whale breeding grounds after court win theguardian.com /2 years ago
Show more
The website finance-news.co is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
